{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:34:12Z","timestamp":1789778052994,"version":"4.0.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"vor","delay-in-days":121,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["089795"],"award-info":[{"award-number":["089795"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["332620"],"award-info":[{"award-number":["332620"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.tem.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T19:15:59Z","timestamp":1488568559000},"page":"377-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Neonatal Diabetes and the K ATP Channel: From Mutation to Therapy"],"prefix":"10.1016","volume":"28","author":[{"given":"Frances M.","family":"Ashcroft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Puljung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascia","family":"Vedovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2017.02.003_bib0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature04711","article-title":"KATP channels as molecular sensors of cellular metabolism","volume":"440","author":"Nichols","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tem.2017.02.003_bib0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0079-6107(89)90013-8","article-title":"Electrophysiology of the pancreatic b-cell","volume":"54","author":"Ashcroft","year":"1989","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.tem.2017.02.003_bib0015","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2017.02.003_bib0020","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/diabetes.54.9.2503","article-title":"Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy","volume":"54","author":"Hattersley","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus","volume":"355","author":"Babenko","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2017.02.003_bib0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00125-003-1143-3","article-title":"Sulphonylurea action revisited: the post-cloning era","volume":"46","author":"Gribble","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2017.02.003_bib0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2017.02.003_bib0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tem.2010.03.004","article-title":"Neonatal diabetes mellitus: a model for personalized medicine","volume":"21","author":"Greeley","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2017.02.003_bib0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cell.2016.12.028","article-title":"Structure of a pancreatic ATP-sensitive potassium channel","volume":"168","author":"Li","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tem.2017.02.003_bib0050","doi-asserted-by":"crossref","first-page":"024149","DOI":"10.7554\/eLife.24149","article-title":"Cryo-EM structure of the ATP?sensitive potassium channel illuminates mechanisms of assembly and gating","volume":"6","author":"Martin","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.tem.2017.02.003_bib0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/humu.20838","article-title":"Update of mutations in the genes encoding the pancreatic b-cell KATP channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism","volume":"30","author":"Flanagan","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.tem.2017.02.003_bib0060","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2337\/db07-0043","article-title":"Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood","volume":"56","author":"Flanagan","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0065","article-title":"Molecular and clinical features of KATP-channel neonatal diabetes mellitus in Japan","author":"Hashimoto","year":"2016","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00125-011-2319-x","article-title":"Heterozygous ABCC8 mutations are a cause of MODY","volume":"55","author":"Bowman","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2017.02.003_bib0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/dc11-1469","article-title":"Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations","volume":"35","author":"Riveline","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2017.02.003_bib0080","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2008.03478.x","article-title":"Mutations in the ABCC8 (SUR1 subunit of the KATP channel) gene are associated with a variable clinical phenotype","volume":"71","author":"Klupa","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2017.02.003_bib0085","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2337\/diabetes.52.2.568","article-title":"Large-scale association studies of variants in genes encoding the pancreatic b-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes","volume":"52","author":"Gloyn","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0090","doi-asserted-by":"crossref","first-page":"17539","DOI":"10.1073\/pnas.0404756101","article-title":"Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features","volume":"101","author":"Proks","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2017.02.003_bib0095","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/519174","article-title":"Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects","volume":"81","author":"Ellard","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tem.2017.02.003_bib0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1399-5448.2009.00548.x","article-title":"Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM","volume":"11","author":"Mohamadi","year":"2010","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1399-5448.2012.00874.x","article-title":"Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11\/S225T, del226-232 mutation","volume":"13","author":"Battaglia","year":"2012","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0110","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-5448.2011.00824.x","article-title":"KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life","volume":"13","author":"Rubio-Cabezas","year":"2012","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1464-5491.2009.02901.x","article-title":"The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue","volume":"27","author":"Shimomura","year":"2010","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2017.02.003_bib0120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/db06-1275","article-title":"An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes","volume":"56","author":"Masia","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0125","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1210\/jc.2007-1826","article-title":"The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy","volume":"93","author":"Koster","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2017.02.003_bib0130","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.1074\/jbc.M112.349019","article-title":"Two neonatal diabetes mutations on transmembrane helix 15 of SUR1 increase affinity for ATP and ADP at nucleotide binding domain 2","volume":"287","author":"Ortiz","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2017.02.003_bib0135","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1016\/j.febslet.2011.10.020","article-title":"Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8)","volume":"585","author":"Babenko","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tem.2017.02.003_bib0140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc07-1785","article-title":"Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations","volume":"31","author":"Rafiq","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2017.02.003_bib0145","unstructured":"DiabetesGenes DiabetesGenes.org. http:\/\/www.diabetesgenes.org\/ (accessed January 2017)."},{"key":"10.1016\/j.tem.2017.02.003_bib0150","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1212\/01.wnl.0000268488.51776.53","article-title":"A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain","volume":"69","author":"Shimomura","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.tem.2017.02.003_bib0155","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1210\/jc.2004-1241","article-title":"Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2","volume":"89","author":"Zung","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2017.02.003_bib0160","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202912","article-title":"A \u2018picturesque\u2019 case of transition from subcutaneous to oral treatment in neonatal diabetes","volume":"2014","author":"Verstappen","year":"2014","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.tem.2017.02.003_bib0165","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s00125-015-3593-9","article-title":"Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes","volume":"58","author":"Thurber","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2017.02.003_bib0170","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2337\/dc09-0280","article-title":"Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect","volume":"32","author":"Kumaraguru","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2017.02.003_bib0175","doi-asserted-by":"crossref","first-page":"jc20162826","DOI":"10.1210\/jc.2016-2826","article-title":"Case report: preservation of reduced numbers of insulin-positive cells in sulfonylurea-unresponsive KCNJ11-related diabetes","volume":"2016","author":"Greeley","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2017.02.003_bib0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000360004","article-title":"Human pancreas endocrine cell populations and activating ABCC8 mutations","volume":"82","author":"Busiah","year":"2014","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.tem.2017.02.003_bib0185","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1038\/ncomms5639","article-title":"Reversible changes in pancreatic islet structure and function produced by elevated blood glucose","volume":"5","author":"Brereton","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2017.02.003_bib0190","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1038\/ncomms13496","article-title":"Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic b-cells","volume":"7","author":"Brereton","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tem.2017.02.003_bib0195","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cmet.2014.03.010","article-title":"Pancreatic b cell dedifferentiation in diabetes and redifferentiation following insulin therapy","volume":"19","author":"Wang","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2017.02.003_bib0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cmet.2008.12.005","article-title":"Secondary consequences of b cell inexcitability: identification and prevention in a murine model of KATP-induced neonatal diabetes mellitus","volume":"9","author":"Remedi","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2017.02.003_bib0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1469-7793.1997.00035.x","article-title":"The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation","volume":"504","author":"Gribble","year":"1997","journal-title":"J. Physiol."},{"key":"10.1016\/j.tem.2017.02.003_bib0210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s002329900178","article-title":"Kinetic analysis of the inhibitory effect of glibenclamide on KATP channels of mammalian skeletal muscle","volume":"155","author":"Barrett-Jolley","year":"1997","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.tem.2017.02.003_bib0215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1085\/jgp.201411222","article-title":"Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2\/SUR1 but not Kir6.2\/SUR2A KATP channels: a mechanistic study","volume":"144","author":"Proks","year":"2014","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.tem.2017.02.003_bib0220","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1085\/jgp.201010475","article-title":"Activation of the KATP channel by Mg-nucleotide interaction with SUR1","volume":"136","author":"Proks","year":"2010","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.tem.2017.02.003_bib0225","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.2337\/db13-1194","article-title":"ATP and sulfonylurea linkage in the KATP channel solves a diabetes puzzler","volume":"62","author":"Drain","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0230","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.2337\/db13-0531","article-title":"Molecular mechanism of sulphonylurea block of KATP channels carrying mutations that impair ATP inhibition and cause neonatal diabetes","volume":"62","author":"Proks","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0235","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.1172256","article-title":"The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs","volume":"325","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.tem.2017.02.003_bib0240","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2337\/db14-0576","article-title":"Role of Epac2A\/Rap1 signaling in interplay between incretin and sulfonylurea in insulin secretion","volume":"64","author":"Takahashi","year":"2015","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.tem.2017.02.003_bib0245","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.2337\/diabetes.51.2007.S33","article-title":"Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action","volume":"51","author":"Renstrom","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0250","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.2337\/db06-0360","article-title":"ATP sensitivity of the ATP-sensitive K+ channel in intact and permeabilized pancreatic b-cells","volume":"55","author":"Tarasov","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0255","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1098\/rsta.2008.0110","article-title":"Cell coupling in mouse pancreatic b-cells measured in intact islets of Langerhans","volume":"366","author":"Zhang","year":"2008","journal-title":"Philos. Trans. A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.tem.2017.02.003_bib0260","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2337\/diabetes.49.11.1751","article-title":"Triggering and amplifying pathways of regulation of insulin secretion by glucose","volume":"49","author":"Henquin","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0265","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s00125-011-2273-7","article-title":"No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes","volume":"54","author":"Iafusco","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2017.02.003_bib0270","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/dc14-1247","article-title":"Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes","volume":"37","author":"Myngheer","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2017.02.003_bib0275","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2010-0096","article-title":"The first case report of sulfonylurea use in a woman with permanent neonatal diabetes mellitus due to KCNJ11 mutation during a high-risk pregnancy","volume":"95","author":"Klupa","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2017.02.003_bib0280","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.2337\/dc12-0163","article-title":"Sulfonylurea use during entire pregnancy in diabetes because of KCNJ11 mutation: a report of two cases","volume":"35","author":"Gaal","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2017.02.003_bib0285","article-title":"Analysis of cell-free fetal DNA for non-invasive prenatal diagnosis in a family with neonatal diabetes","author":"De Franco","year":"2016","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2017.02.003_bib0290","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1464-5491.2007.02228.x","article-title":"Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome)","volume":"24","author":"Sumnik","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2017.02.003_bib0295","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00125-016-3921-8","article-title":"Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes","volume":"59","author":"Babiker","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2017.02.003_bib0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11892-016-0751-5","article-title":"Insulin resistance of puberty","volume":"16","author":"Kelsey","year":"2016","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.tem.2017.02.003_bib0305","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/diabetes.50.11.2444","article-title":"Longitudinal study on pubertal insulin resistance","volume":"50","author":"Goran","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0310","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2337\/db11-0538","article-title":"Acute sulfonylurea therapy at disease onset can cause permanent remission of KATP-induced diabetes","volume":"60","author":"Remedi","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0315","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.2337\/dc14-2124","article-title":"Remission of severe neonatal diabetes with very early sulfonylurea treatment","volume":"38","author":"Marshall","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2017.02.003_bib0320","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1399-5448.2009.00557.x","article-title":"Successful sulfonylurea treatment of an insulin-naive neonate with diabetes mellitus due to a KCNJ11 mutation","volume":"11","author":"Wambach","year":"2010","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0325","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2337\/dc15-0837","article-title":"Sulfonylurea therapy benefits neurological and psychomotor functions in patients with neonatal diabetes owing to potassium channel mutations","volume":"38","author":"Beltrand","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2017.02.003_bib0330","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/dme.13135","article-title":"Psychiatric morbidity in children with KCNJ11 neonatal diabetes","volume":"33","author":"Bowman","year":"2016","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2017.02.003_bib0335","doi-asserted-by":"crossref","first-page":"e62646","DOI":"10.1371\/journal.pone.0062646","article-title":"Gain-of-function mutations in the KATP channel (KCNJ11) impair coordinated hand\u2013eye tracking","volume":"8","author":"McTaggart","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2017.02.003_bib0340","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/hmg\/ddm149","article-title":"Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome","volume":"16","author":"Proks","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2017.02.003_bib0345","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc11-2225","article-title":"Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas","volume":"35","author":"Shah","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2017.02.003_bib0350","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1464-5491.2007.02373.x","article-title":"Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation","volume":"25","author":"Slingerland","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2017.02.003_bib0355","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00125-011-2428-6","article-title":"Mice expressing a human KATP channel mutation have altered channel ATP sensitivity but no cardiac abnormalities","volume":"55","author":"Clark","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2017.02.003_bib0360","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1126\/science.1186146","article-title":"Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes is neuronal in origin","volume":"329","author":"Clark","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.tem.2017.02.003_bib0365","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2337\/dc12-2166","article-title":"Switching to sulphonylureas in children with iDEND syndrome caused by KCNJ11 mutations results in improved cerebellar perfusion","volume":"36","author":"Fendler","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2017.02.003_bib0370","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.physbeh.2014.02.031","article-title":"A mutation causing increased KATP channel activity leads to reduced anxiety in mice","volume":"129","author":"Lahmann","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.tem.2017.02.003_bib0375","doi-asserted-by":"crossref","first-page":"e0134476","DOI":"10.1371\/journal.pone.0134476","article-title":"Systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents","volume":"10","author":"Lahmann","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tem.2017.02.003_bib0380","doi-asserted-by":"crossref","first-page":"20942","DOI":"10.1074\/jbc.M113.470948","article-title":"Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism","volume":"288","author":"Chen","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2017.02.003_bib0385","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/db06-1540","article-title":"New ABCC8 mutations in relapsing neonatal diabetes and clinical features","volume":"56","author":"Vaxillaire","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0390","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s12098-009-0222-y","article-title":"Transient neonatal diabetes due to activating mutation in the ABCC8 gene encoding SUR1","volume":"76","author":"Batra","year":"2009","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.tem.2017.02.003_bib0395","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2337\/diabetes.52.3.767","article-title":"The insulin secretory granule is the major site of K(ATP) channels of the endocrine pancreas","volume":"52","author":"Geng","year":"2003","journal-title":"Diabetes"},{"issue":"Suppl. 3","key":"10.1016\/j.tem.2017.02.003_bib0400","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.2337\/diabetes.53.suppl_3.S59","article-title":"Integration of ATP, cAMP, and Ca2+ signals in insulin granule exocytosis","volume":"53","author":"Shibasaki","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0405","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/aps.2015.134","article-title":"Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis","volume":"37","author":"Li","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tem.2017.02.003_bib0410","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/01.RES.87.10.873","article-title":"C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K+ channels","volume":"87","author":"Matsuoka","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2017.02.003_bib0415","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/CIRCRESAHA.108.178186","article-title":"Differential structure of atrial and ventricular KATP: atrial KATP channels require SUR1","volume":"103","author":"Flagg","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.tem.2017.02.003_bib0420","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yjmcc.2013.04.016","article-title":"Functional roles of KATP channel subunits in metabolic inhibition","volume":"62","author":"Glukhov","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.tem.2017.02.003_bib0425","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/db07-1547","article-title":"A rare mutation in ABCC8\/SUR1 leading to altered ATP-sensitive K+ channel activity and b-cell glucose sensing is associated with type 2 diabetes in adults","volume":"57","author":"Tarasov","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0430","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diabet.2011.12.001","article-title":"A novel ABCC8 mutation illustrates the variability of the diabetes phenotypes associated with a single mutation","volume":"38","author":"Klee","year":"2012","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.tem.2017.02.003_bib0435","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-5491.2008.02443.x","article-title":"Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation","volume":"25","author":"D\u2019Amato","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2017.02.003_bib0440","doi-asserted-by":"crossref","first-page":"e37423","DOI":"10.1371\/journal.pone.0037423","article-title":"Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene","volume":"7","author":"Bonnefond","year":"2012","journal-title":"PLoS"},{"key":"10.1016\/j.tem.2017.02.003_bib0445","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2337\/db09-0025","article-title":"Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance","volume":"58","author":"Villareal","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0450","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/diabetes.51.3.875","article-title":"Kir6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic \u03b2-cell ATP-sensitive K+ channels","volume":"51","author":"Schwanstecher","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0455","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.2337\/db09-0143","article-title":"Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K+ channel","volume":"58","author":"Hamming","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2017.02.003_bib0460","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s00125-016-3964-x","article-title":"Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk","volume":"59","author":"Vedovato","year":"2016","journal-title":"Diabetologia"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327601730019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327601730019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T21:29:20Z","timestamp":1536010160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104327601730019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S104327601730019X"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2017.02.003","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal Diabetes and the KATP Channel: From Mutation to Therapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}